Experience

Davis Polk advised Hangzhou Hikvision Digital Technology Co., Ltd. (“Hikvision”) in connection with its debut issue of €400 million 1.25% notes due 2019. The notes are to be listed on the…

Davis Polk advised the joint bookrunning managers in connection with BPCE’s Section 3(a)(2) offering of $750 million 2.650% notes due 2021 under BPCE’S $25 billion Medium Term Note Program…

Davis Polk is advising the dealer managers on ConAgra Foods’ cash tender offers to purchase up to $1.4 billion aggregate principal amount of its 5.819% senior notes due 2017, its 7.000%…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of 29,884,393 shares of Class B common stock of Molson Coors Brewing Company (…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.250% U.S. dollar bonds due 2019 issued by Export Development Canada. Export…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Novavax, Inc. of an aggregate principal amount of …

Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by Abbott Laboratories. The transaction is subject to the approval of…

Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion acquisition of Sage Products, LLC from Madison Dearborn Partners. The…

Davis Polk advised underwriters in connection with the offering of C$750 million aggregate principal amount of 1.95% bonds due January 27, 2023, issued by the Province of Ontario. The net…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $5.5 billion aggregate principal amount of senior notes, consisting of $2 billion 2.450% fixed…